Electrocardiography, Ambulatory

• 

  Subject Areas on Research

  • 2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society. 
  • 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society. 
  • A pilot study using an implantable device to characterize cardiac arrhythmias in hemodialysis patients: implications for future research. 
  • Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. 
  • Acute changes in heart rate variability in subjects with diabetes following a highway traffic exposure. 
  • Adult patients with congenital heart disease. 
  • Ambulatory Heart Rate Variability Monitoring: Comparisons Between the Empatica E4 Wristband and Holter Electrocardiogram. 
  • Ambulatory cardiovascular activity in Vietnam combat veterans with and without posttraumatic stress disorder. 
  • Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease. 
  • Ambulatory monitoring and physical health report in Vietnam veterans with and without chronic posttraumatic stress disorder. 
  • Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. 
  • Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy. 
  • Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease. 
  • Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. 
  • Atrial fibrillation: what do we know about screening and what do we not know about treatment? 
  • Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). 
  • Biatrial maze procedure versus pulmonary vein isolation for atrial fibrillation during mitral valve surgery: New analytical approaches and end points. 
  • Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is 'paroxysmal' atrial fibrillation? 
  • Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients. 
  • Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. 
  • COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm. 
  • Cardiac sarcoidosis: two cases with autopsy findings. 
  • Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design. 
  • Cigarette smoking, ambulatory cardiovascular monitoring, and mood in Vietnam veterans with and without chronic posttraumatic stress disorder. 
  • Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. 
  • Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndrome. 
  • Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine. 
  • Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36. 
  • Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review. 
  • Depression, heart rate variability, and acute myocardial infarction. 
  • Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients. 
  • Detection of silent myocardial ischemia in diabetes mellitus. 
  • Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. 
  • Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients. 
  • Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. 
  • Distress and affective dysregulation in patients with borderline personality disorder: a psychophysiological ambulatory monitoring study. 
  • Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? 
  • Early experience with intravenous sotalol in children with and without congenital heart disease. 
  • Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. 
  • Effect of digoxin on ST-segment changes detected by ambulatory electrocardiographic monitoring in healthy subjects. 
  • Effects of daily stress on autonomic cardiac control in patients with coronary artery disease. 
  • Effects of mental stress on myocardial ischemia during daily life. 
  • Electrocardiographic monitoring and coronary occlusion. Fingerprint pattern analysis in dimensions of space, time, and mind. 
  • Emotional responsivity and transient myocardial ischemia. 
  • Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms. 
  • Exaggerated heart rate oscillations during two meditation techniques. 
  • Examining the Crux of Autonomic Dysfunction in Posttraumatic Stress Disorder: Whether Chronic or Situational Distress Underlies Elevated Heart Rate and Attenuated Heart Rate Variability. 
  • Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina. 
  • Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. 
  • Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. 
  • From ST-elevation myocardial infarction to ST elevation with no myocardial infarction--review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices. 
  • Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations. 
  • Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. 
  • Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia. 
  • Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. 
  • Hemodynamic stress and experimental aortoiliac atherosclerosis. 
  • Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design. 
  • Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging. 
  • Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group. 
  • Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. 
  • Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. 
  • Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. 
  • Long-term mortality in patients with pauses in ventricular electrical activity. 
  • Longer Ambulatory ECG Monitoring Increases Identification of Clinically Significant Ectopy. 
  • Loss of efficacy during long-term cifenline therapy: development of antiarrhythmic resistance? 
  • Low heart rate variability and the effect of depression on post-myocardial infarction mortality. 
  • Menopausal status, moderate-intensity walking, and symptoms in midlife women. 
  • Mental stress--induced myocardial ischemia and cardiac events. 
  • Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. 
  • Monitoring significant ST changes through deep learning. 
  • Multi-scale heart rate dynamics detected by phase-rectified signal averaging predicts mortality after acute myocardial infarction. 
  • Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery. 
  • Nighttime heart rate and survival in depressed patients post acute myocardial infarction. 
  • Nocturnal patterns of heart rate and the risk of mortality after acute myocardial infarction. 
  • Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. 
  • Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. 
  • Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. 
  • Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach. 
  • Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. 
  • Permanently implantable diagnostic computerized devices: where is the regulatory rar? 
  • Physiological and behavioural response patterns at work among hospital nurses. 
  • Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy. 
  • Posttraumatic stress, heart rate variability, and the mediating role of behavioral health risks. 
  • Potential additional indicators for pacemaker requirement in isolated congenital atrioventricular block. 
  • Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial. 
  • Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. 
  • Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. 
  • Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. 
  • Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI. 
  • Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). 
  • Psychiatric disorders in medical outpatients complaining of palpitations. 
  • RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. 
  • Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study. 
  • Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. 
  • Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: a randomized, prospective clinical investigation. 
  • Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. 
  • Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris. 
  • Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring. 
  • Risk assessment of patients having congenital heart disease using electrophysiologic testing: finally, opening the right door...or, an impossible chore? 
  • Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. 
  • SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. 
  • ST segment depression during labor and delivery. 
  • Stability over time of circadian rhythm of variability of heart rate in patients with stable coronary artery disease. 
  • Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. 
  • Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale. 
  • The clinical course of palpitations in medical outpatients. 
  • The concordance of intraoperative left ventricular wall-motion abnormalities and electrocardiographic S-T segment changes: association with outcome after coronary revascularization. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • The first ISCE Board of "Trustees" overview panel session: ischemia monitoring, state of the art. International Society of Computerized Electrocardiology. 
  • The usefulness of T-wave peak to T-wave end interval in identifying malignant arrhythmias in patients with Chagas disease. 
  • Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. 
  • Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring. 
  • Trauma and Autonomic Dysregulation: Episodic-Versus Systemic-Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder. 
  • US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. 
  • Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring. 
  • Ventricular ectopy: impact of self-reported stress after myocardial infarction. 
  • Wearable Devices in Clinical Trials: Hype and Hypothesis. 
  • What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. 
  • Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology